• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Growth Hormone Releasing Hormone (GHRH) 1-44 Human Amide and Arginine
Date Designated: 03/07/2022
Orphan Designation: Diagnosis of Growth Hormone Deficiency
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Hollenbeck Pharmaceuticals, Inc.
P.O. Box 429
Falls Village, Connecticut 06031
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.